PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Tuberculosis and Respiratory Diseases10.4046/trd.2008.65.3.1772008653177Standard Chemotherapy with Excluding Isoniazid in a Murine Model of TuberculosisTae Sun Shim, Eun Gae Lee, Chang Min Choi, Sang-Bum Hong, Yeon-Mok Oh, Chae-Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Dong Soon Kim, Sang-Nae Cho, Won Dong Kimhttps://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2008.65.3.177, https://synapse.koreamed.org/pdf/10.4046/trd.2008.65.3.177, http://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2008.65.3.177
Antimicrobial Agents and Chemotherapy10.1128/aac.40.2.2981996402298-301Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine modelS P Klemens, M H Cynamonhttps://journals.asm.org/doi/pdf/10.1128/AAC.40.2.298, https://journals.asm.org/doi/pdf/10.1128/AAC.40.2.298
Antimicrobial Agents and Chemotherapy10.1128/aac.43.12.2922199943122922-2924High-Dose Isoniazid Therapy for Isoniazid-Resistant Murine Mycobacterium tuberculosis InfectionM. H. Cynamon, Y. Zhang, T. Harpster, S. Cheng, M. S. DeStefanohttps://journals.asm.org/doi/pdf/10.1128/AAC.43.12.2922, https://journals.asm.org/doi/pdf/10.1128/AAC.43.12.2922
Chemotherapy10.1159/0002218081974203183-200Rifampicin plus Isoniazid, Rifampicin plus PAS, and Isoniazid plus PAS in the Initial Treatment of Pulmonary TuberculosisJ. TouĊĦek, R. Votrubahttps://www.karger.com/Article/Pdf/221808, https://www.karger.com/Article/Pdf/221808
Antibiotics and Chemotherapy10.1159/000386838352-360Rifampicin1, 2, Isoniazid, Ethambutol, Ethionamide, and Streptomycin in Murine Tuberculosis : Comparative Chemotherapeutic StudiesF. Kradolferhttps://www.karger.com/Article/Pdf/386838, http://www.karger.com/Article/Pdf/386838
Antimicrobial Agents and Chemotherapy10.1128/aac.02981-1420145874048-4053Reduced Emergence of Isoniazid Resistance with Concurrent Use of Thioridazine against Acute Murine TuberculosisNoton K. Dutta, Michael L. Pinn, Petros C. Karakousishttps://journals.asm.org/doi/pdf/10.1128/AAC.02981-14, https://journals.asm.org/doi/pdf/10.1128/AAC.02981-14
Chemotherapy10.1159/00032104520105717-11Isoniazid Blood Levels in Patients with Pulmonary Tuberculosis at a Tuberculosis Referral CenterFanak Fahimi, Farzad Kobarfard, Payam Tabarsi, Shabnam Hemmati, Jamshid Salamzadeh, Shadi Baniasadihttps://www.karger.com/Article/Pdf/321045, https://www.karger.com/Article/Pdf/321045, https://www.karger.com/Article/Pdf/321045
Antimicrobial Agents and Chemotherapy10.1128/aac.40.3.5521996403552-555Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamideJ Dhillon, J M Dickinson, K Sole, D A Mitchisonhttps://journals.asm.org/doi/pdf/10.1128/AAC.40.3.552, https://journals.asm.org/doi/pdf/10.1128/AAC.40.3.552
Tubercle10.1016/s0041-3879(67)80047-3196748111-26Late results of long-term, intermittent chemotherapy of advanced, murine tuberculosis: Limits of the murine modelF. Grumbach, G. Canetti, J. Grosset, M. Le Lirzinhttps://api.elsevier.com/content/article/PII:S0041387967800473?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0041387967800473?httpAccept=text/plain
Tuberculosis and Respiratory Diseases10.4046/trd.1971.18.3.519711835-13An Experimental Study on Isoniazid plus Thiacetazone Chemotherapy in Experimental Mice TuberculosisEung Kyoo Choihttp://e-trd.org/upload/pdf/trd-18-3-5.pdf, http://e-trd.org/journal/view.php?doi=10.4046/trd.1971.18.3.5, http://e-trd.org/upload/pdf/trd-18-3-5.pdf